Cargando…
Lung-targeted SERCA2a Gene Therapy: From Discovery to Therapeutic Application in Bleomycin-Induced Pulmonary Fibrosis
Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease characterized by an accumulation of scar tissue within the lungs and the common presence of usual interstitial pneumonia. Unfortunately, only a few FDA-approved therapeutic options are currently available for the treatment of IPF an...
Autores principales: | Bisserier, Malik, Hadri, Lahouaria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316402/ https://www.ncbi.nlm.nih.gov/pubmed/32587955 |
Ejemplares similares
-
Current and emerging therapeutic approaches to pulmonary hypertension
por: Bisserier, Malik, et al.
Publicado: (2020) -
Targeting epigenetic mechanisms as an emerging therapeutic strategy in pulmonary hypertension disease
por: Bisserier, Malik, et al.
Publicado: (2019) -
Molecular and Genetic Profiling for Precision Medicines in Pulmonary Arterial Hypertension
por: Fazal, Shahood, et al.
Publicado: (2021) -
Novel Insights into the Therapeutic Potential of Lung-Targeted Gene Transfer in the Most Common Respiratory Diseases
por: Bisserier, Malik, et al.
Publicado: (2022) -
Combination Therapy with STAT3 Inhibitor Enhances SERCA2a-Induced BMPR2 Expression and Inhibits Pulmonary Arterial Hypertension
por: Bisserier, Malik, et al.
Publicado: (2021)